Sengenics | GenomeWeb

Sengenics

The companies are launching new clinical exome sequencing services called Exomax.

Sengenics has been employing the technology, which uses arrays of full-length, folded proteins, with a number of pharma clients for the last several years.

Sengenics is rebranding the technology Immunome and expects it to expand the company's footprint in the proteomics space.

NEW YORK (GenomeWeb) – Sengenics said this week that it has exclusively partnered with Sequenom to launch that company's VisibiliT non-invasive prenatal test in Thailand, Indonesia, and Brunei.

Kuwaiti molecular diagnostics firm Genatak has begun offering a targeted hereditary breast cancer panel and exome sequencing services for patients with cancer, undiagnosed genetic disorders, and individuals looking to understand disease risk.

NEW YORK (GenomeWeb News) – The Genome Institute of Singapore and Sengenics said today that they have formed a partnership to identify and validate auto-antibody signatures for the early detection of cancers.

NEW YORK (GenomeWeb News) – Sengenics and Parkway Laboratory Services have entered into a partnership to offer genetics tests in Singapore, Sengenics said on Thursday.

NEW YORK (GenomeWeb News) – CollabRx today announced a deal with Sengenics to incorporate each other's products into molecular diagnostics tests and reports aimed at cancer.

Oxford Gene Technology, a UK firm perhaps better known for its menu of chromosomal microarrays and foundational array IP, has seen its protein array platform emerge from the shadows in recent weeks after signing an agreement that gives its main partner in Asia the ability to offe

Sengenics said this week that it will launch a cancer biomarker discovery and clinical trial immunoresponse monitoring service based on Oxford Gene Technology's functional protein array platform.

Pages

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.